RxDoctor Payments Data

Sean Branch, DO

Dermatology · Gulf Breeze, FLNPI 1124333232

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $177,056 of the $201,033 with a category attached, or 88.1%. 26 manufacturers reported payments, led by Pfizer at 32.7% of the total. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$201,033in general payments, 2019–2025

Across 551 payments — averaging $364.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$66K
  • Galderma Laboratories, L.p.$50K
  • AbbVie$34K
  • Incyte Corporation$30K
  • UCB, Inc.$17K
  • Novartis$1K
  • plus $3K from 20 others
$33,933in research payments, 2019–2025

Across 5 payments — averaging $6786.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$34K

What the payments were for

  • Speaking & faculty fees$177,05688%
  • Travel & lodging$12,4066%
  • Food & beverage$11,3336%
  • Education$2370%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$201,033 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024
$264,848
Medicare patients
695
Services billed
3,689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab21$101,155
Clobetasol Propionate42$2,632
Triamcinolone Acetonide167$2,086
Ketoconazole77$1,182
ValacyclovirValacyclovir Hcl30$474
Hydrocortisone34$419
Doxycycline Hyclate23$365
Fluconazole20$213
Terbinafine Hcl19$166
Mupirocin19$116
Cephalexin16$72
Prednisone14$70

Paid to pharmacies, not to this prescriber.

Other dermatology in Gulf Breeze

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →